A REAL-WORLD OBSERVATIONAL STUDY OF ETELCALCETIDE USE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM IN EUROPE

被引：0

作者：

Louie, Karly ^{[1
]}

Papadopoulou, Dorothea ^{[2
]}

Hoffmann, Maxime ^{[3
]}

Escola, Joaquin Manrique ^{[4
]}

Kohnle, Matthias ^{[5
]}

Cejka, Daniel ^{[6
]}

Piccoli, Giorgina ^{[7
,8
]}

Rix, Marianne ^{[9
]}

Boots, Johannes ^{[10
]}

Pernat, Andreja Marn ^{[11
]}

Torregrosa, Vicente ^{[12
]}

Tsirtsonis, Kate ^{[1
]}

Fouqueray, Bruno ^{[13
]}

Floege, Juergen ^{[14
]}

机构：

[1] Amgen Lth, Uxbridge, Middx, England

[2] Papageorgiou Hosp, Dept Nephrol, Thessaloniki, Greece

[3] Private Hosp La Louviere Ramsay Healthcare, Dept Nephrol & Dialysis, Lille, France

[4] Complejo Hosp Navarra, Nephrol Serv, Pamplona, Spain

[5] Nephrol Zentrum Mettmann, Mettmann, Germany

[6] Ordensklinikum Linz Elisabethinen, Dept Med 3, Nephrol, Transpantat Med,Rheumatol,Geriatr, Linz, Austria

[7] Ctr Hosp Le Mans, Le Mans, France

[8] Univ Torino, Turin, Italy

[9] Univ Hosp Copenhagen, Rigshosp, Dept Nephrol, Copenhagen, Denmark

[10] Maasstad Hosp, Dept Internal Med & Nephrol, Rotterdam, Netherlands

[11] Univ Med Ctr, Ljubljana, Slovenia

[12] Univ Barcelona, Hosp Clin, Nephrol & Renal Transplant Dept, Barcelona, Spain

[13] Amgen GmbH, Rotkreuz, Switzerland

[14] Rhein Westfal TH Aachen, Div Nephrol, Aachen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

P0794

引用

页码：1122 / 1122

页数：1

共 50 条

[1] A Real-World Observational Study of Calcimimetic Use in Hemodialysis (HD) Patients with Secondary Hyperparathyroidism (SHPT) in Europe
Nduka, Chidozie U.
Pernat, Andreja Marn
Camerini, Corrado
Cejka, Daniel
Ladanyi, Erzsebet
Piccoli, Giorgina B.
Boots, Johannes M.
Torregrosa, Jose-Vicente
Labriola, Laura
Rix, Marianne
Hall, Matthew
Kohnle, Matthias
Tsirtsonis, Kate
Fouqueray, Bruno L.
Floege, Juergen
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 209 - 209
[2] Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life"
Russo, Domenico
Tripepi, Rocco
Malberti, Fabio
Di Iorio, Biagio
Scognamiglio, Bernadette
Di Lullo, Luca
Paduano, Immacolata Gaia
Tripepi, Giovanni Luigi
Panuccio, Vincenzo Antonio
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07):
[3] Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore
Khan, Behram A.
Qu, Xiaojie
Hua, Yan
Javaid, Muhammad M.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
[4] EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
Massimetti, Carlo
Borzacchi, Silvia
Feriozzi, Sandro
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 565 - 565
[5] Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study
Massimo Morosetti
Ljiljana Jankovic
Laura Zappalà
Elena Agafonova
Iryna Pryshlyak
International Urology and Nephrology, 2023, 55 : 1865 - 1873
[6] Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study
Morosetti, Massimo
Jankovic, Ljiljana
Zappala, Laura
Agafonova, Elena
Pryshlyak, Iryna
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (07) : 1865 - 1873
[7] Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
Monciino, Paola
Magagnoli, Lorenza
Fasulo, Eliana
Frittoli, Michela
Leotta, Chiara
Pham, Hoang Nhat
Stucchi, Andrea
Ciceri, Paola
Galassi, Andrea
Cozzolino, Mario
KIDNEY AND DIALYSIS, 2022, 2 (03): : 482 - 494
[8] CLINICAL IMPACTS OF ETELCALCETIDE IN PATIENTS RECEIVING HEMODIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN JAPAN
Ito, Minoru
Masakane, Ikuto
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
[9] Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in "Real Life" (vol 8, 1066, 2019)
Russo, Domenico
Tripepi, Rocco
Malberti, Fabio
Di Iorio, Biagio
Scognamiglio, Bernadette
Di Lullo, Luca
Paduano, Immacolata Gaia
Tripepi, Giovanni Luigi
Panuccio, Vincenzo Antonio
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[10] Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
Cunningham, John
Block, Geoffrey A.
Chertow, Glenn M.
Cooper, Kerry
Evenepoel, Pieter
Iles, Jan
Sun, Yan
Urena-Torres, Pablo
Bushinsky, David A.
KIDNEY INTERNATIONAL REPORTS, 2019, 4 (07): : 987 - 994

← 1 2 3 4 5 →